Search filters

List of works by Claire M Perks

A feasibility randomised controlled trial of short-term fasting prior to CAPOX chemotherapy for stage 2/3 colorectal cancer: SWiFT protocol

scientific article published on 20 November 2019

Actions of IGFBP on epithelial cancer cells: potential for new therapeutic targets.

scientific article published on November 2003

Activated Akt expression in breast cancer: correlation with p53, Hdm2 and patient outcome.

scientific article published in May 2005

Adipogenesis and IGF-1

scientific article published on 01 January 2006

Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate Cancer

scientific article published in 2021

Blood lipids and prostate cancer: a Mendelian randomization analysis

scientific article published on 19 March 2016

CDC2-like (CLK) protein kinase inhibition as a novel targeted therapeutic strategy in prostate cancer

scientific article published on 12 April 2021

Caffeine and Caffeic Acid Inhibit Growth and Modify Estrogen Receptor and Insulin-like Growth Factor I Receptor Levels in Human Breast Cancer

scientific article

Current Understanding of Circulating Tumor Cells - Potential Value in Malignancies of the Central Nervous System

scientific article

Developing the WCRF International/University of Bristol Methodology for Identifying and Carrying Out Systematic Reviews of Mechanisms of Exposure-Cancer Associations

scientific article

Dietary restriction during the treatment of cancer: results of a systematic scoping review

scientific article published on 15 August 2019

Dihydrotestosterone sensitises LNCaP cells to death induced by epigallocatechin-3-Gallate (EGCG) or an IGF-I receptor inhibitor.

scientific article published on February 2009

Does milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysis

scientific article

Effects of physiological levels of the green tea extract epigallocatechin-3-gallate on breast cancer cells

scientific article

Elucidating the novel BRCA1 function as a non-genomic metabolic restraint in ER-positive breast cancer cell lines

scientific article published on 11 September 2018

Epigenetic regulation of insulin-like growth factor binding protein-3 (IGFBP-3) in cancer

scientific article published on 29 April 2015

Epithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor-binding protein 3?

scientific article

Grand challenges in cancer endocrinology: endocrine related cancers, an expanding concept.

scientific article published on 08 October 2013

Green tea extract (epigallocatechin-3-gallate) reduces efficacy of radiotherapy on prostate cancer cells

scientific article published on 14 June 2011

Growth hormone and cancer: are we asking the right questions?*

scientific article published on 01 February 2006

How growth hormone may be linked to cancer: concerns and perspective

scientific article published on 01 November 2007

Hyperglycaemia confers resistance to chemotherapy on breast cancer cells: the role of fatty acid synthase.

scientific article published on 18 May 2010

Hyperglycaemia-induced chemoresistance in breast cancer cells: role of the estrogen receptor.

scientific article published on 8 December 2015

Hyperglycaemia-induced chemoresistance of prostate cancer cells due to IGFBP2.

scientific article published on 11 September 2013

Hyperglycaemia-induced resistance to Docetaxel is negated by metformin: a role for IGFBP-2.

scientific article published on 17 October 2016

Hyperglycemia Promotes TMPRSS2-ERG Gene Fusion in Prostate Cancer Cells via Upregulating Insulin-Like Growth Factor-Binding Protein-2.

scientific article published on 6 November 2017

Hypoxia negates hyperglycaemia-induced chemo-resistance in breast cancer cells: the role of insulin-like growth factor binding protein 2.

scientific article

IGF binding proteins (IGFBPs) and regulation of breast cancer biology.

scientific article

IGFBP-1 expression is reduced in human type 2 diabetic glomeruli and modulates β1-integrin/FAK signalling in human podocytes

scientific article published on 24 March 2021

IGFBP-2/PTEN: A critical interaction for tumours and for general physiology?

scientific article

IGFBP-3 Can Either Inhibit or Enhance EGF-mediated Growth of Breast Epithelial Cells Dependent upon the Presence of Fibronectin

scientific article published on September 17, 2010

Immunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcome.

scientific article

Inhibition of FASN and ERα signalling during hyperglycaemia-induced matrix-specific EMT promotes breast cancer cell invasion via a caveolin-1-dependent mechanism.

scientific article published on 10 January 2018

Insulin Receptor Isoform Variations in Prostate Cancer Cells

scientific article published on 28 September 2016

Insulin-like growth factor binding protein 2 (IGFBP-2) promotes growth and survival of breast epithelial cells: novel regulation of the estrogen receptor.

scientific article published on 20 March 2013

Insulin-like growth factor binding protein 3 has opposing actions on malignant and nonmalignant breast epithelial cells that are each reversible and dependent upon cholesterol-stabilized integrin receptor complexes.

scientific article published on 13 April 2006

Insulin-like growth factor binding protein-3 (IGFBP-3) plays a role in the anti-tumorigenic effects of 5-Aza-2'-deoxycytidine (AZA) in breast cancer cells.

scientific article published on 26 June 2013

Insulin-like growth factor physiology: what we have learned from human studies.

scientific article published on 08 May 2012

Insulin-like growth factor-II in adipocyte regulation: depot-specific actions suggest a potential role limiting excess visceral adiposity

scientific article published on 24 July 2018

Insulin-like growth factor-II is produced by, signals to and is an important survival factor for the mature podocyte in man and mouse.

scientific article

Insulin-like growth factor-binding protein-1 (IGFBP-1) regulates human schwannoma proliferation, adhesion and survival.

scientific article

Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxel

scientific article published on April 12, 2011

Interaction between GRP78 and IGFBP-3 Affects Tumourigenesis and Prognosis in Breast Cancer Patients

scientific article published on 18 December 2020

Intrinsic, Pro-Apoptotic Effects of IGFBP-3 on Breast Cancer Cells are Reversible: Involvement of PKA, Rho, and Ceramide

scientific article published on 16 May 2011

Investigation of the Interplay between Circulating Lipids and IGF-I and Relevance to Breast Cancer Risk: An Observational and Mendelian Randomization Study

scientific article published in 2021

Loss of PTEN expression is associated with IGFBP2 expression, younger age, and late stage in triple-negative breast cancer

scientific article published on March 2014

Prolactin acts as a potent survival factor against C2-ceramide-induced apoptosis in human granulosa cells.

scientific article

Prolactin acts as a potent survival factor for human breast cancer cell lines.

scientific article published on July 2004

Prostate cancer - evidence of exercise and nutrition trial (PrEvENT): study protocol for a randomised controlled feasibility trial.

scientific article published on 7 March 2016

Reassessing the Association between Circulating Vitamin D and IGFBP-3: Observational and Mendelian Randomization Estimates from Independent Sources

article

Role of the IGF axis in prostate cancer.

scientific article published on June 2012

Systemic Metabolism, Its Regulators, and Cancer: Past Mistakes and Future Potential

scientific article published on 12 February 2019

The role of insulin-like growth factor binding proteins.

scientific article published on 13 October 2006

p14ARF expression in invasive breast cancers and ductal carcinoma in situ--relationships to p53 and Hdm2

scientific article